홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

데오라제팜

Delorazepam

HCID 17925
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
2894-67-9
표준 SMILES
O=C1CN=C(c2ccccc2Cl)c2cc(Cl)ccc2N1
InChIKey
CHIFCDOIPRCHCF-UHFFFAOYSA-N
분자식
C15H10Cl2N2O
평균 분자량
305.2 g/mol
단동위원소 질량
304.0170183

개요

Delorazepam is a benzodiazepine.

이름 및 식별자

우선 이름
Delorazepam
IUPAC
7-chloro-5-(2-chlorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
현지명
데오라제팜
영어명
Delorazepam
분자식
C15H10Cl2N2O
분자량
305.16

이름 및 동의어

Delorazepam2894-67-9ChlordemethyldiazepamB1, BenzodiazepineCl-DMDZ2-Chloronordiazepam2'-chloronordiazepamDadumirRo 5-3027RV-121652H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-7-chloro-5-(2-chlorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
이름 더 보기
데오라제팜EN7-Chloro-1,3-dihydro-5-(2-chlorophenyl)-2H-1,4-benzodiazepin-2-one7-Chloro-5-(2-Chlorophenyl)-1,3-Dihydro-3H-1,4-Dibenzodiazopine-2-OneE5NTL-VAPCALJAL-VAP-2
NSC-169895DTXSID70183137O91W32476G1,3-Dihydro-7-chloro-5-(o-chlorophenyl)-2H-1,4-benzodiazepin-2-onechlorodesmethyldiazepamNSC169895RefChem:5856737-chloro-5-(2-chlorophenyl) 1,3-dihydro-2H-1,4-benzodiazepin-2-one

데이터베이스 식별자

CAS
2894-67-9
PubChem CID
17925
DTXSID
DTXSID70183137
ChEMBL
CHEMBL268254
ChEBI
CHEBI:135295
UNII
O91W32476G
EC Number
220-771-9
Nikkaji
J7.928F

물성

구조 계산 물성보충 중

XLogP
3.1
극성 표면적
41.5 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
2
회전 가능 결합 수
1
무거운 원자 수
20
형식 전하
0
복잡도
413

실험 및 물리화학적 성질

Drugs · 4건

DEA NFLIS-Drug Category -> Benzodiazepines

DEA Schedule IV Controlled Substance -> Depressants

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds

LogP3.15
Human DrugsPharmaceuticals

물리화학적 성질

녹는점
187 · 187-189°C
끓는 점
481.7 · 481.7±45.0 °C(Predicted)
밀도
1.42 · 1.42±0.1 g/cm3(Predicted)
인화점
11 °C · 11 °C
저장 조건
2 · 2-8°C
용해도
30 mg/ml; · DMF: 30 mg/ml; DMSO: 30 mg/ml; DMSO:PBS(pH7.2) (1:1): 0.5 mg/ml; Ethanol: 10 mg/ml
산도 계수 (pKa)
11.58 · 11.58±0.70(Predicted)
물리적 상태
완충 수용액
생물학적 소스
mouse
InChIKey
CHIFCDOIPRCHCF-UHFFFAOYSA-N
NIST
Delorazepam(2894-67-9)

화학적 성질

Off-White to Light Yellow Solid

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Warning

H302 (97.6%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 42 reports by companies from 2 notifications to the ECHA C&L Inventory.

유해성 정보

Regulatory Information · 2건

DEA schedule IV controlled substance

REACH registered substance: Delorazepam (EC: 220-771-9)

Hazard Classes and CategoriesAcute Tox. 4 (97.6%)

독성 정보

Treatment · 1건

General supportive measures should be employed, along with intravenous fluids, and an adequate airway maintained. Hypotension may be combated by the use of norepinephrine or metaraminol. Dialysis is of limited value. Flumazenil (Anexate) is a competitive benzodiazepine receptor antagonist that can be used as an antidote for benzodiazepine overdose. In particular, flumazenil is very effective at reversing the CNS depression associated with benzodiazepines but is less effective at reversing respiratory depression. Its use, however, is controversial as it has numerous contraindications. It is contraindicated in patients who are on long-term benzodiazepines, those who have ingested a substance that lowers the seizure threshold, or in patients who have tachycardia or a history of seizures. As a general rule, medical observation and supportive care are the mainstay of treatment of benzodiazepine overdose. Although benzodiazepines are absorbed by activated charcoal, gastric decontamination with activated charcoal is not beneficial in pure benzodiazepine overdose as the risk of adverse effects often outweigh any potential benefit from the procedure. It is recommended only if benzodiazepines have been taken in combination with other drugs that may benefit from decontamination. Gastric lavage (stomach pumping) or whole bowel irrigation are also not recommended.

Exposure Routes · 1건

77-87% oral bioavailability, with a relatively slow absorption rate. Reaches peak plasma levels within 1-2 hours of administration. Food may slow absorption, however other pharmacokinetic variables remain unchanged. After multiple doses delorazepam accumulates, however accumulation is slower in younger patients.

Toxicity Summary · 1건

Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.

Signs and SymptomsOlder patients metabolize delorazepam slower than younger patients and thus suffer from more adverse effects.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

안전 데이터

wgk
3
rtecs
DF2367500
ridadr
UN 1230 3/PG 2
독성
LD50 oral in rat: 2gm/kg
risk_code
22-39/23/24/25-23/24/25-11
hazard_code
Xn,T,F
safety_code
36/37/39-45-36/37-16-7
스토리지 클래스
10 - Combustible liquids

화학 및 산업

약리 정보

Protein Binding>90% protein bound.
Biological Half-LifeVery long elimination half life of 80-115 hours, varying with age. Elimination is slower as age increases. [1] Liver disease also impacts elimination half life, with impairment resulting in half lives up to 395 hours.
Metabolism/Metabolites · 2건

Delorazepam is metabolized at a relatively slow pace by the liver. The major metabolite (15-34% of the parent drug) is lorazepam. Older patients metabolize delorazepam slower than younger patients.

Delorazepam is metabolized at a relatively slow pace by the liver. The major metabolite (15-34% of the parent drug) is lorazepam. Older patients metabolize delorazepam slower than younger patients.

MeSH Pharmacological ClassificationDrugs used to prevent SEIZURES or reduce their severity.
Absorption, Distribution and Excretion · 4건

77-87% oral bioavailability, with a relatively slow absorption rate. Reaches peak plasma levels within 1-2 hours of administration. Food may slow absorption, however other pharmacokinetic variables remain unchanged. After multiple doses delorazepam accumulates, although accumulation is slower in younger patients.

Renally eliminated.

140 L/kg apparent volume of distribution in 11 patients with normal renal function; 47 L/kg in 11 patients with renal failure and on regular hemodialysis. In another study, apparent volume of distribution was 65 L/kg in 8 patients with liver disease and 118.4 L/kg in 12 healthy controls.

Still detectable 72 hours after dosing in healthy patients. Patients with liver disease experienced a reduction in clearance from 0.13 to 0.25 ng/mLh.

용도 및 제조

Uses · 1건

Mainly used as an anti-anxiety agent. Studies have found delorazepam to be more effective in the first 4 weeks of use than antidepressants; however, after 4 weeks, antidepressants showed superior anti-anxiety effects. Anti-anxiety effects also appear to be weaker in elderly patients. Effectiveness has also been observed in the treatment of alcohol withdrawal. Delorazapam was reported to be a manageable drug in that it did not exhibit severe side effects and did not require further therapies to control symptoms of withdrawal.

Use ClassificationPharmaceuticals

응용 분야

용도Controlled Substance

관련 반응

9건
반응 기록 만들기
HRID 649264 반응식
HRID 649264반응물로
HRID 649266 반응식
HRID 649266반응물로
HRID 673356 반응식
HRID 673356반응물로
HRID 805703 반응식
HRID 805703반응물로
HRID 1076389 반응식
HRID 1076389반응물로
HRID 1138462 반응식
HRID 1138462반응물로
HRID 1148992 반응식
HRID 1148992반응물로
HRID 1156237 반응식
HRID 1156237반응물로
이전1 / 2 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트